Cambridge Investment Research Advisors’s iShares Emerging Markets Equity Factor ETF EMGF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Sell
10,514
-208
-2% -$14.6K ﹤0.01% 2549
2026
Q1
$648K Buy
10,722
+4,697
+78% +$293K ﹤0.01% 2575
2025
Q4
$349K Buy
6,025
+931
+18% +$53.6K ﹤0.01% 3045
2025
Q3
$288K Buy
+5,094
New +$275K ﹤0.01% 3140
2021
Q3
– Sell
-5,334
Closed -$289K – 3122
2021
Q2
$289K Buy
5,334
+580
+12% +$31K ﹤0.01% 2499
2021
Q1
$247K Buy
+4,754
New +$247K ﹤0.01% 2434

Other funds holding EMGF

Cambridge Investment Research Advisors's EMGF Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its iShares Emerging Markets Equity Factor ETF (EMGF) stake by 1.9% in Q2 2026, selling an estimated $14.6K and leaving 10,514 shares worth $770K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Cambridge Investment Research Advisors first reported a position in EMGF in Q1 2021 and has held it in 6 quarters since. 233 funds tracked by Wall St. Rank hold EMGF as of Q2 2026.

  • Cambridge Investment Research Advisors held 10,514 shares of iShares Emerging Markets Equity Factor ETF worth $770K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 208 iShares Emerging Markets Equity Factor ETF shares in Q2 2026, an estimated $14.6K.
  • iShares Emerging Markets Equity Factor ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2549 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares Emerging Markets Equity Factor ETF in Q1 2021 and has held it in 6 quarters since.
  • 233 funds tracked by Wall St. Rank held iShares Emerging Markets Equity Factor ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.